Do ginger footbaths improve symptoms of insomnia more than footbaths with warm water only? - A randomized controlled study.

Circadian rhythm Distal-proximal skin temperature gradient Footbath Ginger Hydrotherapy Insomnia Warmth perception Zingiber officinale

Journal

Complementary therapies in medicine
ISSN: 1873-6963
Titre abrégé: Complement Ther Med
Pays: Scotland
ID NLM: 9308777

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 16 11 2021
revised: 13 04 2022
accepted: 15 04 2022
pubmed: 20 4 2022
medline: 6 5 2022
entrez: 19 4 2022
Statut: ppublish

Résumé

To compare the effects between warm water (WW) and ginger footbaths (WW+ginger) on sleep quality and warmth regulation in adults with self-reported insomnia symptoms. A prospective randomized-controlled study in which 28 participants (mean age 50.9 years, 64.3% women, insomnia symptom duration 11.4 years) were randomized to receive WW (n = 13) or WW+ginger (n = 15) daily for 2 weeks. Treatment involved nightly footbaths (12 liters of 38-42 °C warm tap water, maximum duration 20 min) with and without topical ginger (80 g of powdered ginger rhizomes). The primary outcome measure was self-reported sleep quality (global score from Pittsburgh Sleep Quality Index, PSQI) at 2 weeks. Secondary outcomes included measures of insomnia severity (Insomnia Severity Index, ISI) and warmth regulation (Herdecke Warmth Perception Questionnaire, HWPQ and 24-hour distal-proximal skin temperature gradient, DPG). WW+ginger had no greater effect on PSQI (mean between-difference 0.0 [95% CI -3.0 to 2.9], Cohen's d=0.0) or ISI (-0.2 [-3.9 to 3.4], 0.0) than WW. Nor were there any significant differences in HWPQ perceived warmth (0.1 ≥d≥0.5) or DPG (0.1 ≥d≥0.4) between WW and WW+ginger. Both groups improved over time in PSQI (WW+ginger: d=0.7, WW: d=1.3) and ISI (WW+ginger: d=0.8, WW: d=1.0). Perceived warmth of the feet increased only in WW+ginger over time (d=0.6, WW: d=0.0). This dose of ginger (6.67 g/liter) did not have greater effects on sleep quality, insomnia severity or warmth regulation than WW. Considering effect sizes, costs and risks, the use of WW would be recommended over WW+ginger in this patient population.

Identifiants

pubmed: 35439548
pii: S0965-2299(22)00036-X
doi: 10.1016/j.ctim.2022.102834
pii:
doi:

Substances chimiques

Water 059QF0KO0R

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

102834

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Silja Kuderer (S)

Research Department, ARCIM Institute (Academic Research in Complementary and Integrative Medicine), Im Haberschlai 7, 70794 Filderstadt, Germany.

Katrin Vagedes (K)

Research Department, ARCIM Institute (Academic Research in Complementary and Integrative Medicine), Im Haberschlai 7, 70794 Filderstadt, Germany.

Henrik Szöke (H)

Department of Integrative Medicine, University of Pécs, Vörösmarty utca 3, 7623 Pécs, Hungary.

Matthias Kohl (M)

Institute of Precision Medicine, University Furtwangen, Jakob-Kienzle-Straße 17, 78054 VS-Schwenningen, Germany.

Stefanie Joos (S)

Institute for General Practice and Interprofessional Care, University Hospital Tübingen, Osianderstraße 5, 72076 Tübingen, Germany.

Peter W Gündling (PW)

Hochschule Fresenius, University of Applied Sciences, Limburger Str. 2, 65510 Idstein, Germany.

Jan Vagedes (J)

Research Department, ARCIM Institute (Academic Research in Complementary and Integrative Medicine), Im Haberschlai 7, 70794 Filderstadt, Germany; Department of Neonatology, University Hospital Tübingen, Calwerstraße 7, 72076 Tübingen, Germany; Department of Pediatrics, Filderklinik, Im Haberschlai 7, 70794 Filderstadt, Germany. Electronic address: j.vagedes@arcim-institute.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH